MENU
PMN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ProMIS Neurosciences (PMN) Ownership - Who owns ProMIS Neurosciences?
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA)... Show more
Profile
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
6
Web
https://www.promisneurosciences.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.23M
P/E Ratio
5.35
Total Cash
21.57M
Projected Growth
N/A
Total Debt
4.05M
Revenue
N/A
Risk (Beta)
-0.52
Dividend Yield
N/A
Total Cash/Share
0.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PMN
Capitalization
19.2M
P/E Ratio
5.35
Risk (Beta)
-0.52
Dividend Yield
N/A
Total Cash
21.6M
Total Cash/Share
0.66
Total Debt
4.05M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.27M
P/B Ratio
1.17
Cash Flow
N/A
Earnings
0.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
9.30
Current Revenue Per Employee
695.39
Dividends Per Share - Security
N/A
EBITDA
-391.76K
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-2.66
Shares Held By Institutions
9.27M
Shares Outstanding - Current
32.7M
Total Liabilities
17.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-37.919
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
6
Web
https://www.promisneurosciences.com